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a b s t r a c t
The remarkable growth of bio-based industry has led to a rapid increase in the bioprospect-
ing activities. The marine biomes are a rich reservoir of unique life systems making them
an attractive target for bioprospecting for identification and development of potential drug
molecules for human therapeutics. Many of the drug molecules such as ara-c, trabecetidin
and eribulin have been discovered frommarine organisms. It is noteworthy that indigenous
communities have developed, preserved as well as evolved the marine traditional knowl-
edge from one generation to next. Pharmaceutical companies utilize marine life based tra-
ditional knowledge developed by the communities at various stages of drug development,
unfortunately, many a times without having a mechanism of access and benefit sharing
in place. One such example is the marine bioprospecting Fiji contract that illustrates the
role played by Fijian community and the lacuna in access and benefit sharing mechanisms.
The present study is an attempt to explore the mechanism of fair and equitable sharing of
the benefits arising from use of marine bioresources with the local communities as ma-
rine traditional knowledge holders inmarine areas. It briefly describes the various interna-
tional conventions and protocols that emphasize on the development of fair and equitable
benefit sharing mechanisms. The study proposes marine bioprospecting contracts that are
based onmutually agreed terms among the key stakeholders (the Statewith the genetic re-
sources, traditional knowledge holders andmarine bioprospectors).Marine bioprospecting
contracts eventually will need to be customized as per the legislation of a country because
of territorial nature of law. Also, the marine bioprospecting contracts will differ from other
bioprospecting contracts due to various unique parameters associated with the activity
such as economics of deep sea explorations (expensive processes of exploration and sample
extraction), continuous supply of sample, the jurisdiction of marine areas and traditional
knowledge associated. The present study elucidates the concept of marine bioprospecting
contracts by considering India as a case study emphasizing sharing of benefits with tradi-
tional knowledge holders as well as ensuring sustainable use of marine genetic resources
by the pharmaceutical sector.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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1. Introduction
Nature has always been a source of inspiration and has played a critical role in drug discovery and development process (Ji
et al., 2009). Drug molecules and compounds were identified from plants, animals and microorganisms. Slowly the interest
from terrestrial to marine bioresources has shifted as a result of the adventitious properties offered by the marine chemical
compounds (Montaser and Luesch, 2011).Marine ecosystems are unique and rich reservoir of biodiversitywith an enormous
potential towards improving the quality of human life. Themodernmedicine systemendeavours tomakeuse of thesemarine
flora and fauna in several possible ways. Pharmaceutical sector is the major area that is actively building its inventory
of marine bioresource based/derived drugs. Some of the determining parameters for increased corporate interest in the
marine genetic resources include requirement to combat multi drug resistant, novel drug discovery that is low shelf life
of conventional drugs and increasing market demand of bio-based drugs. Marine organisms have highly developed defense
system in order to survive in the hostile conditions such as extreme temperatures, varied pressures (low or high), low energy
and lack of sunlight.
Thus, marine organisms offer a unique genetic pool that may possess the potential of treating several diseases including
rare diseases or the ailments that are still considered incurable (Demunshi and Chugh, 2010; Lazcano-Pérez et al., 2012).
This can be effectively deduced from the successfully FDA approved drugs (Table 1) such as Cytarabine (Ara-C), vidarabine
(Ara-A), ziconotide, trabectedin, eribulin mesylate (Mayer et al., 2010; Martins et al., 2014). Marine organisms also find use
asmodel organism from the perspective of understanding various fundamental phenomenon of life which have not been yet
unravelled. One such example is elucidation of vertebrate development process through zebrafish embryo (Ingham, 1997).
Interestingly, the bioprospecting practices using marine bioresources are not new as indigenous communities have been
dependent on these resources for food, medicine and livelihood since the inception of human civilization. However, as to-
day’s world progresses towards the age of the bio based economy, bioprospecting activities for several reasons including
human health care have increased rapidly. Bioprospecting in general has been defined in various ways by different authors
and organizations. ‘‘TRIPS, CBD and Traditional Medicines: Concepts and Questions’’, a World Health Organisation Publica-
tion (Timmermans, 2001), defines bioprospecting as the systematic search for and development of new sources of chemical
compounds, genes, micro-organisms, macro-organisms, and other valuable products from nature.
Four major phases of bioprospecting activity have been described by Leary (2007) as shown in Fig. 1. The phases range
from sample collection, isolation, characterization to product (drug) development and commercialization. Bioprospecting
does not only comprise of a provider and an acceptor but the entire process of bioprospecting involves various components
including the owner(s) of marine genetic resources, the bioprospectors, research and development group (if separate from
the bioprospector) and end product users. These components are highly interdependent on each other as well as on the
genetic resource (Fig. 2).
It is noteworthy that bioprospecting in general has an inherent element of uncertainty with respect of the quantum
of returns and also the protocols used for bioprospecting are complex as well as time and cost intensive. Therefore,
return on investment is a major point of consideration by the pharmaceutical companies for investing in marine research
and development. The pharmaceutical companies tend to protect the identified compounds of interest and the collected
information under proprietary regime because of the huge investments involved in explorations, collection of sample and
screening of the compounds which may every time require optimization of new protocol. Drugs of pharmaceutical interest
derived from the marine organisms are protected through various tools of intellectual property law but mainly via patent
regime. It has been observed that in the recent times there is a sharp rise in the patenting of products and processes
derived from marine bioresources such as sponges, jelly fish, seaweeds (Demunshi and Chugh, 2009; Siswandi, 2013).
Interestingly, a close relation exists between innovations (patents) and marine traditional knowledge (Vierros et al., 2010).
The marine indigenous communities depend on marine resources for their livelihood, food and medicine. The wealth of
marine traditional knowledge developed by these communities has been passed from one generation to next and both the
communities as well as their surrounding marine habitat survive in a sustainable manner thereby preserving the marine
ecosystem (Demunshi andChugh, 2010). Themarine traditional knowledge also exists in the alternative traditionalmedicine
systems of marine biodiversity rich countries (Alves, 2006).
Pharmaceutical companies besides conducting expeditions to identify novel bioresources for pharmaceutical com-
pounds, also often base their exploration for a marine organism of pharmaceutical interest based on the traditional knowl-
edge developed by the indigenous communities. It is primarily opted by the pharmaceutical companies as it saves time for
random screening and investment for collating basal information such as habitat, time of reproduction, population density
etc. However, there aremany instances of biopiracy of marine life and associated traditional knowledge as the access toma-
rine genetic resources has been without the knowledge of the State or the indigenous marine communities (Singh, 2000).
The communities have been deprived of fair and equitable sharing of the benefits arising from the commercialization of their
knowledge. According to Global Industry Analysts, marine bioresourceswere expected to give rise to ‘marine biotechnology’
products worth over $3.75 bn by 2012, particularly functional ingredients for nutritionals, cosmetics and pharmaceuticals
(Meredith, 2010) and while according to another market report by TechNavio, the marine biotech market is anticipated to
grow at a CAGR of 3.82% over the period 2012–2016 (Global Marine Biotech Market, 2012–2016).
Thus, with ever increasing population, there is augmentation in demand and a niche market for bio based products such
as bio-drugs, alternative fuels supporting clean technologies and sustainable development. The ever increasing demand
would in turn enhance marine bioprospecting activities. Thereby, raising the urgent need for developing mechanisms such
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Table 1
FDA and EMEA approved marine based drugs.
S.no Compound Organism
1. Cytarabine (Ara-C) Sponge Tethya crypta
2. Vidarabine (Ara-A) Sponge Tethya crypta
3. Ziconotide Cone snail Conus magus
4. Trabectedin Marine tunicate Ecteinascidia turbinata
5. Eribulin mesylate Sponge Halichondria okadai.
6. Cephalosporin C, Marine fungi
7. Omega-3 fatty acids Fish oil
8. Dolastatin 10 Sea Hare Dolabella auricularia
Fig. 1. Overview of bioprospecting phases.
as contracts, as an essential component for an efficient benefit sharingmechanisms among grassroot stakeholders inmarine
bioprospecting sector. As mentioned above, the economics of deep sea exploration is much higher, there is uncertainty of
supply of sample in deep sea bioprospecting and concerns about the jurisdictions thereby, making it difficult to regulate
deep sea bioprospecting. However, contracts can still be a tool to regulate the deep sea bioprospecting. The present work
focuses on assessing the position of various benefit sharing mechanisms associated with marine bioprospecting and the
international legal instruments that promote the concept of fair and equitable benefit sharing to the indigenous communities
as key stakeholders in the marine bioprospecting activity.
The concept of access to genetic resources and benefit sharing is distinctly described in theUnitedNation’s Convention on
Biological Diversity. Article 8 (j) of the Convention recognizes the importance of the knowledge, practices, and innovations
of indigenous and local communities. Article 15 of the Convention on Biological Diversity emphasizes on public or private
enterprise to obtain prior informed consent seeking access to biodiversity resources. Further, the third objective of the
Convention as provided in the Article 1 is to ensure fair and equitable sharing of benefits along with access to the genetic
resources. Many of the biodiversity and associated traditional knowledge rich countries are making an attempt to introduce
legislations that focus on the access and benefit sharing system in accordance with the Convention on Biological Diversity.
Intellectual property rights especially patents under the Trade Related Intellectual Property Rights (TRIPS) regime have been
considered an important tool for revenue generation. However, the Convention on Biological Diversity and the Trade related
Intellectual Property Rights are not mutually supportive (Carr, 2008; Chugh, 2010).
Therefore, marine bioprospecting contracts can serve as a significant instrument for developing robust benefit sharing
mechanisms and recognition for the traditional knowledge basedmarine bioprospecting. It is also envisaged that contractual
models can ensure enhanced protection and sustainable use of the marine resources and the associated traditional
knowledge. In the present study, India being a marine biodiversity rich nation has been employed as a case study for
developing marine bioprospecting contracts. As discussed above, CBD is one international convention that focuses on
conservation of biodiversity and benefit sharing among the stakeholders. Similarly there are other international treaties
and organizations that have been established for regulating bioprospecting activities. Section 3 of the present study provides
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Fig. 2. Inter-linkages between the stakeholders of marine bioprospecting activity.
information on the various international instruments in form of treaties, guidelines, protocols that have evolvedwith regard
to bioresources including marine genetic resources. However, firstly the study discusses international organization and law
provisions thatmay have relevance on ABS today and in future. The impact of these international organizations with respect
to marine bioprospecting activities has been also analysed.
Various bioprospecting contracts executed till now have been examined, to evaluate the benefits accrued to the
traditional knowledge holders. Terrestrial and marine bioprospecting agreements have been evaluated in terms of the
provisions to sustain sample supply, conservation and access and benefit sharing mechanisms. The various agreements
talk about improving livelihood of the local communities and conservation of the environment. Detailed analysis has been
provided in Section 3. Further the study assesses howa jurisdiction specific contract canbe evolved to ensure socio-economic
development of traditional knowledge stakeholders and protect the marine biological diversity.
2. Method
The present study has been conducted in context of the marine bioprospecting contracts and access and benefit sharing
among the traditional knowledge stakeholders. The publications in form of papers and reports on use of contracts for
ensuring access and benefit sharing and sustained use of marine biodiversity with respect to bioprospecting globally
and in Indian context were searched. Further search has been carried out employing a combination of search terms:
bioprospecting, marine bioresources, traditional knowledge, contracts, access benefit sharing. Information on relevant
treaties and international organizations has been obtained from governmental reports or academic papers and electronics
sources such as websites. As the focus of the study is to develop a model contract for use in India as an example, Bare Acts
of the relevant Indian legislation have been also examined.
3. International organizations and law provisions
Recognizing the relevance of regulating the activities in the marine areas due to sharp rise in the marine bioprospecting
activities and an urgent need to restrict the unregulated use of marine biodiversity and promote its conservation, various
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Table 2
Various legal instruments and organizations related to coastal genetic resources regulation.
S.no Legal instrument/organization Key features Reference
1 Convention on Biological Diversity (CBD) • Govern the different aspects of marine scientific research Demunshi and Chugh (2010)
• Share the benefits arising from the utilization of genetic
resources in a fair and equitable way
2 Bonn guidelines and Nagoya Protocol • Access to genetic resources Nagoya Protocol (2012)
• Specialized access and benefit sharing regimes consistent
with the objectives of the CBD
•Meet the ethical concerns, competing requirements between
freedom of scientific research
• Exploitation of a resource and benefit to the source owner and
society at large
• Use of traditional knowledge associated with genetic
resources within the scope
3 United Nations Convention on the Law of
the Seas (UNCLOS)
• Defines the rights and responsibilities of nations with respect
to their use of the world’s oceans
UNCLOS (1982)
• Establishing guidelines for businesses, the environment, and
the management of marine natural resources
4 International Sea Bed Authority • Provides rules and provisions to regulate prospecting,
exploration and exploitation of marine minerals in the
international seabed area
5 Global Ocean Commission • Recommend policies for governance in the high seas
• Recommend amendment of UNCLOS
• Enable governance at the regional level
6 European Science Foundation • Envisages to develop principles on the simplification and
harmonization of regulations on access and fair and equitable
benefit sharing arising from the exploitation of marine genetic
resources
Querellou et al. (2010)
7 Valencia Declaration • Governance regime for the regulation of activities in the
marine areas
8 European Micro B3 • Development of standards for sampling of marine
microorganism
MicroB3 (2014)
instruments as well as organizations have evolved in the past years. The different instruments and organizations playing
relevant role in bioprospecting have been listed in Table 2. Treaties such as Convention on Biological Diversity (CBD), United
Nations Convention on the Law of the Seas (UNCLOS) and World Intellectual Property Organisation (WIPO) to govern
the different aspects of marine scientific research have been adapted (Demunshi and Chugh, 2010). However, till date
despite its specific and unique requirements, there is no specific legislation that describes the regulation and benefit sharing
mechanism for marine bioprospecting per se. The International Sea Bed Authority provides rules and provisions to regulate
prospecting, exploration and exploitation of marine minerals in the international seabed area, in order to conserve the
marine environment (International Seabed Authority, 2012).
The United Nations Convention on the Law of the Seas nor the Convention on Biological Diversity discusses bioprospect-
ing in common international waters, consequently, clear the governance policies with respect to use of marine resources
and associated traditional knowledge have not evolved much (Leroux and Mbengue, 2010). The Convention on Biological
Diversity is a legal instrument that aims at conservation of biological diversity but does not specify marine biodiversity.
The Bonn guidelines and Nagoya Protocol of CBD has been discussed in detail in this regard in the next subsection. Lallier
et al. (2014) have evaluated the relationship of the CBD, the Nagoya Protocol of CBD and the United Nations Convention on
the Law of the Seas in reference to marine genetic resources highlighting that marine bioprospecting remains unregulated
in international waters, beyond the national jurisdiction. The Global Ocean Commission, an initiative in UK, has evolved to
recommend policies for governance in the high seas with the objective to protect the environment and prevention of deple-
tion of resources. The Commission is recommending amendment of UNCLOS and enabling governance at the regional level
(Global Ocean Commission, 2014). The Antarctic Treaty is another region specific treaty that focuses on the Antarctic region
and aims at protection of Antarctic seals, mining activities and environment conservation.
Also the Valencia Declaration on the Protection of Marine Biodiversity urges for an international governance regime for
the regulation of activities in themarine areas beyond the national jurisdictions and to ensure use of the resources for benefit
of the mankind with a balanced approach (MarBEF + Outreach: A plea for the Protection of Marine Biodiversity Valencia
and Declaration, 2008). The European Science Foundation in its recent position paper onmarine biotechnology envisages to
develop principles on the simplification and harmonization of regulations on access and fair and equitable benefit sharing
arising from the exploitation of marine genetic resources. These principles consider three marine sources from where
the genetic resources can be used from: inside Europe, outside Europe and international waters (Querellou et al., 2010).
The European Micro B3 (Microbial Biodiversity, Bioinformatics and Biotechnology) project has resulted in development of
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standards for sampling of marine microorganism and proposed agreements for access and benefit sharing in such cases
(MicroB3, 2014).
Unfortunately, most of the international legal instruments do not address specific issue of the access to marine genetic
resources with prior consent and benefit sharing by the traditional knowledge holders nor take into account the custom law
of the region. However, from the review of the current legislation, it is clear that there is an urgent need to evolve robust, fair
and equitable sharing mechanism for marine traditional knowledge holders along with focus on sustainable use of marine
biodiversity.
3.1. Bonn Guidelines and Nagoya Protocol of the Convention on Biological Diversity
Following the Convention on Biological Diversity, 1992, the member states enacted national legislations to meet the re-
quirements of the Convention including India. Threemain objectives have been laid down in the Convention onBiological Di-
versity, 1992 (Convention on Biological Diversity, 2012) as Article 15 to get permission before the resources and knowledge
are collected (‘‘Prior Informed Consent’’); to agree on the terms for exchange (‘‘Mutually Agreed Terms’’), and to share bene-
fits fairly with local providers (traditional knowledge holders; indigenous communities) and countries (‘‘Fair and Equitable
Benefit-Sharing’’). Based on the Convention on Biological Diversity, protocols and guidelines on access and benefit sharing
have also been established to supplement the Convention. The Bonn Guidelines on access to genetic resources and fair and
equitable sharing of the benefits arising out of their utilization, 2002, is an implementation tool for the Article 15 of the Con-
vention on Biological Diversity. The Bonn guidelines provide only indicative clauses and elements for a general bioprospect-
ing contract. However, for implementation of effective benefit sharing mechanism, a framework for contractual clauses and
regulatory guide lines that are specific to marine bioprospecting are required for the reasons discussed in previous section.
Similarly, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from
their Utilization to the Convention on Biological Diversity aims to achieve the development of specialized access and benefit
sharing regimes that are consistent with the objectives of the Convention on Biological Diversity (Nagoya Protocol, 2012).
The main focus of the Protocol is perceived to meet the ethical concerns, competing requirements between freedom of
scientific research, exploitation of a resource and benefit to the source owner and society at large. The Nagoya Protocol also
applies to traditional knowledge associated with genetic resources within the scope of the Convention and to the benefits
arising from the utilization of such knowledge. The protocol has been ratified by 36members and yet to be ratified by the 14
more members to be enforced. In order to monitor the status and implementation of the Nagoya Protocol, it was decided in
the tenth meeting of the Convention to hold the next eleventh meeting in India in the year 2012 from 8th to 17th October.
In the eleventh meeting, the members were requested to expedite the process of ratification.
Measures were proposed to raise awareness on importance of genetic resources and associated traditional knowledge,
and related access and benefit-sharing issues to facilitate ratification of the Nagoya Protocol. In the meeting modalities for
a global multilateral sharing mechanism were discussed. The eleventh meeting had an agenda item specifically covering
marine and coastal biodiversity, focusing on identification of ecologically and biologically significant marine and coastal
areas and matters related to the marine and coastal areas for consideration by the Conference of Parties. The study
on traditional, scientific, technical and technological knowledge of indigenous and local communities carried out in the
identified marine and coastal areas were discussed in the meeting. The areas identified and studied include North-East
Atlantic, Western South Pacific region, Greater Caribbean and Mid-Atlantic region and the Mediterranean region. The
Conference of Parties also considered the reports on ocean acidification, coral bleaching, voluntary guidelines for applying
environmental impact assessment and strategic environmental assessment in marine areas and impact of environmental
assessment on the marine biodiversity.
Although, the agenda of the meeting was elaborate and focused on the marine and the coastal biodiversity, however,
inclusion of the critical points of maintaining the marine resources and preserving traditional knowledge related to these
areas, were still missing. Guidelines for utilizing the marine traditional knowledge and provisions towards economic as
well as societal incentives to the traditional knowledge holders were not included during the meeting by the Conference
of the Parties (Conference of Parties 11, 2012). Although, measures have been proposed in the meeting to implement the
Nagoya Protocol, however, the Nagoya protocol per se currently does not provide a framework on which the contracts or
the contractual clauses can be built on, nor it proposes any guidelines to be followed for access and benefit sharing for
the marine resources. Nonetheless, it is distinctly clear from the review of various international frameworks pertaining to
marine bioresources are attempting to emphasize on the development of equitable benefit sharing mechanism for marine
bioprospecting activities. Such developments also indicate that contracts will form an important component of benefit
sharing mechanism for the marine traditional knowledge holders (mainly indigenous communities).
Nonetheless, role of bioprospecting contracts has been assessed and realized at various forums that also appreciate
the significance of contribution of traditional knowledge holders in the bioprospecting activities. As discussed earlier,
contracts can be a vital tool that can play significant role in encouragingmarine bioprospecting activitieswith prior informed
consent and mutually agreed terms for its access and benefit sharing by the traditional knowledge stakeholders. The
present study attempts to analyse the important parameters that should be kept into consideration while drafting marine
bioprospecting contracts for safeguarding the interests and promoting welfare of indigenous communities as traditional
knowledge stakeholders and conservation of marine bioresources.
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Table 3
A comparison of the major terrestrial bioprospecting contracts.
Contract Parties Type and term Scope Benefits to the indigenous
communities
INBio-Merck INBio-National Biodiversity
Institute of Costa Rica and Merck &
Co. Ltd
Renewable
non-exclusive 2
year
Evaluation of limited numbers of
plant, insect and Microbial samples
from 11 conservation areas
– US$1 million
– Equipment for processing
samples
– Scientific training
Peruvian ICBG, Bristol, Monsanto, Glaxo,
Wellcome
Renewable 5
years
Collection of Peruvian medicinal
plants
Lumpsum payment.
Suriname
Maroon tribes
ICBG, Virginia Polytechnic Institute
and State University; Conservation
International; Bedrijf
Geneesmiddelen Voorziening
Suriname; Missouri Botanical
Gardens and Bristol-Myers Squibb
Pharmaceutical Research Institute
Renewable 5
years
Collection of botanical and
ethnobotanical samples, inventory,
extraction of compounds, screening
of bioactivity and drug
development
– Technical capacity building
to prepare the plant extracts.
– Laboratory equipment and
the training to use the
equipments.
Kerala, India TBGRI and Arya Vadiya Pharmacy 11 years Plants with the help of Kani
community
– Lump sum.
– Royalty.
– Training in local sample
preparation and screening.
– Protection of biodiversity.
4. Role of contracts in access and benefit sharing
Various legal instruments pertaining to genetic resources emphasize that the access to genetic resourcesmay be allowed
onmutually agreed terms and sharing the resulting benefitswith the stakeholders (including traditional knowledge holders;
Suneetha and Pisupati, 2012) as discussed in the section above. Contracts will play a major role in developing the concept of
‘mutually agreed terms’ for marine bioprospecting activities. In order to make any arrangement binding it is important that
a contract is clearly written and is enforceable indicating that contracts and laws of contracts are deeply integrated with
the complex benefit sharing system (Young, 2009; Geary et al., 2013). The territorial nature of the laws further adds to the
complexity of system of access and benefit sharing. The major issues concerning in a contract are ownership related, access
to genetic resources, sovereignty, jurisdiction, monitoring, benefit generation and sharing and the conservation of genetic
resource.
4.1. Bioprospecting contracts
Bioprospecting contracts play an essential role in overcoming the complications of the access and benefit sharing
by providing monitoring provisions for the entire activity of bioprospecting while ensuring a balanced approach. The
bioprospecting contracts are primarily based on the three objectives as laid down in the Article 15 of the Convention on
Biological Diversity. In order to have a valid contract and to monitor each stage, a centralized body needs to be set up
that is responsible for signing contracts, negotiating, issuing permits, monitoring bio sampling, handling of samples and
transportation of the samples. The State should be involved to ensure equitable sharing of monitoring benefits for the
communities who hold the knowledge rather than just an individual or a particular community enjoying the benefits, as
the knowledge holders number may exceed beyond one community and beyond a single region. The signing of the contract
is not the final stage, monitoring is the key to a successful contract. Monitoring is required for identification of sample, date
of exportation and place for tracking purpose, evaluation of collection method, sampling quantity to avoid overharvesting,
environmental impact assessment, as well as for associated benefit sharing.
It is clear that the access and benefit sharing system is rapidly evolving due to the steep increase in the bioprospecting
activities for novel drug development in the pharmaceutical sector. To ensure that the benefits are shared among themarine
traditional knowledge stakeholders (indigenous communities) and sustainable use of marine bioresources, bioprospecting
contracts have been executed by the resource rich countries and the pharmaceutical enterprises. One of the most well
known bioprospecting contract is the contract executed between the INBio-national biodiversity institute of Costa Rica, and
Merck Pharmaceutical Ltd (Eberlee, 2000). The contract granted the right for collection as well as evaluation of plant, insect
and microbial samples from Costa Rica’s 11 forest conservation areas (also see Table 3). Another agreement pertaining to
bioprospecting, is the agreement executed between ICBG (International Cooperative Biodiversity Group, US: governmental
venture) and Bristol-Myers Squibb, Monsanto, and Glaxo Wellcome (consortium of private companies) for collection of
Peruvian medicinal plants. ICBG has executed contracts with different organizations for the bioprospecting activities.
One of the contracts involves the Suriname Maroon tribes that depend on the forest resources for their survival and
in due course of time they have developed extensive knowledge on the application of the biological resources (Guérin-
McManus et al., 1999). Similarly in Kerala, India a renewable contract between TBGRI (Tropical Botanical Garden and
Research Institute, a public sector institution) and Arya Vaidya Pharmacy Coimbatore Ltd was executed involving the Kani
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Community (WIPO Database of Biodiversity-related Access and Benefit-sharing Agreements, 2012). A comparison of each
of the above bioprospecting contracts in terms of parties, duration, scope and benefits is provided in Table 3. Interestingly,
most of the bioprospecting contracts relate to terrestrial bioprospecting as described above.
4.2. Marine bioprospecting contracts
Marine bioprospecting differs from terrestrial bioprospecting in various important aspects. As discussed before, diverse
marine life with immense pharmaceutical importance exists in marine areas. The territorial jurisdiction of many of such
marine areas is difficult to assess and fall under the common heritage of mankind, thus raising the complexity of resource
ownership. In the present section ‘marine bioprospecting contracts’ has been discussed and relevant examples have been
analysed. A specific example of marine bioprospecting contract is the Fiji contract that was executed by the University of
South Pacific and the bioprospecting company SmithKline Beecham, and laterwith an instituteGlasgowStrathclyde Institute
of Drug Research. The Agreement offered advantages of conservation of biodiversity, upliftment of the community and rights
to the community to intervene such as the communitywas given the right to reclaim the sample after one year alternatively,
the license was for a shorter duration of one year for the evaluation of the sample. However, there is no provision that deals
with protection of traditional knowledge as the contract was executed to collect the samples for research by the University
of South Pacific, independent of the associated marine traditional knowledge (Geer and Harvey, 2004; Aalbersberg et al.,
1997). The Agreement also failed to meet the first condition of the CBD wherein, prior consent of the community before
commercialization was not sought.
As observed in the case of terrestrial bioprospecting contracts (Table 3), the conditions for access, benefits in terms of
societal and monetary were mentioned in the contracts. Similarly, these terms and conditions pertaining to access, various
societal benefits such as training to the community, funding for conservation of biodiversity, or monetary benefits and the
mode of payment can also be incorporated in the marine bioprospecting contracts. Most of the bioprospecting contracts
are based on milestone payment based system (Young, 2009) that can serve as a promising tool for benefit sharing by the
traditional knowledge holders (generally indigenous community) and the State in case of any project failure. One time lump
sum bioprospecting fees serves not only as an impediment to the company that wishes to obtain samples but also fails to
serve as an incentive for the traditional knowledge holders or the State whose resources are being used. In order to have
the milestone based system of the fee disbursement towards bioprospecting, the whole process can be divided into various
phases by evaluation and identification. On the basis of the phases that may include sampling, transfer of information,
laboratory testing of the samples, the payment can be based on the identified milestone thus serving as a fair system for
obtaining information and compensating the indigenous community for the knowledge shared. Milestone based payment
is also beneficial due to the fact that the time between collection of sample and eventual production of the product to its
launch into the market is very lengthy, as it involves numerous time intensive steps.
The first step in any bioprospecting project is collection of samples and in case the milestone based payment system
is to be used, it is essential to have the sample valuation. In case of a technology or patent, it is still possible to carry out
valuation however, it is difficult to carry out valuation of the biogenetic resource sample per se. Therefore, appropriate
methods need to be devised to carry out the valuation of the biological samples. Devising methods for the valuation of
terrestrial bioprospecting samples have been attempted by economists and scientists (Lesser and Krattiger, 2007). However,
in case of marine bioresources it becomes more tedious, as the same marine resources may be found in the areas beyond
the national jurisdiction that are considered as common heritage and appropriate method for sample valuation are lacking
in such cases (Koyama, 2008).
As described earlier, marine bioprospecting contracts need to be different from other bioprospecting contracts as they
deal with marine traditional knowledge, skilled sample collection and processing and much more huge investments and
technological advancements. Additionally, the marine bioprospecting contracts should have the scope to address the issue
of ownership, monitoring and regulation of bioprospecting activities in areas beyond the national jurisdictions. Also efforts
need to be channelized towards minimizing the effect of monopoly and providing research and development opportunity
for the bioresource country. At the same time, mechanisms to reduce the risk for the pharmaceutical companies have to
be explored. The process of drug discovery and drug development is long, the duration of the contract can be stipulated in
such a manner that staggered payments as discussed in the section above, can be made by the concerned company on each
successful milestone achievement by both or either of the parties. The conservation and protection of the marine resources
is a challenge, especially when there is no governing national or international regime regulating the associated activities
such as marine bioprospecting. The contracts should ensure that the recipient party does not imbalance the population of
species, threatening its existence. The contracts in fact can serve as a strategic and effective tool for conservation of marine
biodiversity as well as ensuring its sustainable use, thus, making a marine biodiversity rich nation, an attractive platform
for marine bioprospecting related activities.
Therefore, succinct and enforceable marine bioprospecting contracts addressing the above issues and complexities need
to be developed. A contract can be enforceable provided it is vetted and drafted within the provision of the requirements
of the national laws of a country where it has to be executed. Thus, the contracts are indeed country specific. In the present
study an attempt has been made to develop a marine bioprospecting contract taking India as an example. It is noteworthy
that India has a huge coastline with rich marine biodiversity and traditional knowledge developed by the indigenous
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communities over generations. The alternative or traditional medicine systems of India also employ marine organisms in
formulations for human disease treatment (Gopal et al., 2008).
5. Marine bioprospecting contracts: India as a case study
India has a wide spread of marine ecosystem surrounded by Arabian Sea in the west, Bay of Bengal in the east, and
Indian Ocean in the south. The length of coastline of India, including the coastlines of Andaman and Nicobar Islands in the
Bay of Bengal and Lakshwadweep Islands in the Arabian Sea sums up to 7517 km (Kumar et al., 2006). India has a total
exclusive economic zone of 2,305,143 square km. India being a rich State not only in biodiversity but also with respect to
different languages and culture, has facets that are unique to it and in order to arrive at an effective contract, it should
be specific to the Indian needs and legal requirements. Evaluating the different types of contracts for bioprospecting and
adapting an appropriate model that conforms to the specific requirements of India and Indian legislation is an important
challenge. The Biological Diversity Act, 2002 of India was enacted in line with the Convention of Biological Diversity and
includes provisions for access to genetic resources and fair and equitable benefit sharing. Foreign entities require approval
of National Biodiversity Authority established as per Section 3 of The Biological Diversity Act, 2002, before undertaking
any bioprospecting activity or transferring results of research related to the biodiversity. Applicants filing applications for
registration or grant of intellectual property rights also need to seek permission from the Authority.
Equitable benefit sharing is also decided by the Authority as given under section 21 of the Act making it clear that a
framework to ensure equitable benefit sharing is in the process of evolution. The Act has empowered the State Biodiversity
Boards under Section 7 of the Act to approve collection of biological resources. As in any other international or national plat-
form, there are no specific or distinct provisions in the Biological Diversity Act, 2002 for regulation ofmarine bioprospecting.
Therefore, it remains to be seen whether current Biological Diversity Act, 2002 will be able to handle the issues specific to
utilization of marine life for bioprospecting activities. According to Section 10 of the Indian Contract Act, 1872 ‘‘All agree-
ments are contracts, if they are made by the free consent of the parties, competent to contract, for a lawful consideration
with a lawful object, and not hereby expressly to be void’’. Moreover, the parties making the offer and accepting the offer
should be competent to enter the contract as per Section 11 of the Contract Act of India. Any agreement to be a valid contract
needs to have clause(s) on consideration that can be either monetary or non-monetary or both.
As contracts will connect the pharmaceutical company with traditional knowledge holding indigenous communities in
more than one ways, the contract should be also available in the local language as it will have long term implications for
benefit sharing and encourage active participation of the indigenous communitymembers. A copy of this contract should be
submitted to the relevant State authority. Ambiguous terms should be avoided to ensure clarity on mutually agreed terms
in the contract. Thus, a section on definitions is essential to provide the scope and limitations of a term used in the contract
such as the bioprospector, provider should be mentioned for all the participating parties. The subject matter of the consent
and conditions of consent should be clearly stated in the contract as they will make the contract less ambiguous or open
ended. In order to ensure enforceability of the contract, arbitration clauses, governing law and clauses on breach of contract
should be included. The assignment of rights to third party without the consent of either of the parties will be a detriment to
each of the party, thereby the clause on conditions on assignment of rights to third party must be included in the contract.
Liability and indemnity clauses against the other party and third party should be included.
Since traditional knowledge is a community centric knowledge, the customary laws of the indigenous community should
be also considered in the contract, thereby, meeting the criteria of access to genetic resources by mutually agreed terms
and benefit sharing. Fig. 3 illustrates the important aspects of a marine bioprospecting contract ensuring benefit sharing
mechanism by the indigenous communities and sustainable use of marine genetic resources. Such inclusions in marine
bioprospecting contracts are important as they can be communicative bridge between the pharmaceutical companies and
traditional knowledge holding indigenous communities. Although, the proposed guideline for the marine bioprospecting
contract is limited to the marine areas under the national jurisdiction (Box 1), however, they can be extended to the marine
areas under commonheritage regulated by treaties such as Antarctic Treaty. The role of allmember nationswill be significant
in developing access and benefit sharing mechanism for the indigenous communities in such areas.
6. Awareness creation: a vital step towards successful access and benefit sharing system
Traditional knowledge holders (indigenous communities such as tribals, rural communities) are often the key
stakeholders in access and benefit sharing agreements, thus requiring awareness about the concept of access and benefit
sharing mechanism for their socio-economic development and welfare. Besides capacity building, legal and strategic
assistance should be made available to such traditional knowledge holders. As observed in the Fiji case study, a marine
bioprospecting arrangement can be considered effective and successful only if all the stakeholders such as the traditional
knowledge holding indigenous communities are given due recognition and benefits of varied kind. Further, creating
awareness regarding the impact of collaborative marine bioprospecting among the indigenous communities equips the
community andmakes themonitoring process easy. The Government can also incentivize the traditional knowledge holders
to ensure participation of the communities and locals in themarine bioprospecting activities. The community representative,
along with an authorized State officer should represent in the interactions as significant stakeholders at all levels with the
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Fig. 3. Schematic overview of model contract components.
pharmaceutical companies. The members of indigenous local community should also ensure that they understand all the
stipulations stated in the contract. The community should be persistent on receiving due recognition and adequate sharing
of benefits rising from the resources used and information dissipated.
Awareness creation regarding marine biodiversity resources and bioprospecting as discussed earlier among the
traditional knowledge holders and Government officials is the key to make the access to the marine resources and benefit
sharing system among the stakeholders successful. An authority consisting of members from the local area should be in
continuous mode of interaction with the local people. Courses and training workshops should be conducted regularly
for the indigenous community members to re-emphasize the socio-economic and cultural importance of the knowledge
they hold and the ways to effectively protect the knowledge while bringing benefits for their community development.
These workshops should also make the traditional knowledge holders aware of the assistance schemes provided by the
government and how they can be availed. Pamphlets, information brochures and guides printed in local languages would
contribute towards the raising the level of awareness among the traditional knowledge holding indigenous communities.
At the same time, awareness for the recognition and benefit sharing based on use of marine genetic resources through
workshops, conferences and interactive seminars should be raised among the scientific community involved in marine
life based research activities. Also knowledge about the national laws, policies and regulations for marine bioprospecting
activities should be disseminated among researchers. Significance of socio-cultural and economic impact on indigenous
traditional knowledge stakeholders should be noted by the scientists as it will bring due recognition to the efforts
of indigenous traditional knowledge holders as well as bridge the gap between various stakeholders highlighting the
significance of benefit sharing and sustainable use of marine biodiversity.
7. Conclusion
Marine biodiversity is an attractive genetic resource pool owing to the unique characteristics of the marine organisms
conferred by the extreme conditions of the marine environment. The indigenous communities across the continents have
been using these marine bioresources for various purposes including disease treatment. Thus, marine organisms are an
important source for novel drug development for the contemporary pharmaceutical industry as can be seen from the
increase in reports and publications on the new compounds isolated from the marine bioresources. The blue gold rush has
increased the bioprospecting activities in themarine areas involving various collaborations, partnerships and joint ventures
among institutes and companies. Therefore, it is envisaged that agreements such as contracts will take the centre stage
of marine bioprospecting activities. Well laid guidelines that will curb biopiracy of marine organisms as well as provide
recognition to the traditional knowledge holding communities are the need of the hour. Amendments in the relevant
intellectual property regime and framing of sui genersis mechanisms can also contribute towards curbing biopiracy. State
level organizations can play an important role in raising the awareness among the stakeholders especially the traditional
knowledge holding communities.
It is foreseen that there will be unprecedented commercialization of marine bioresources for pharmaceutical purposes
leading to increase dependence on the indigenous communities for their knowledge onmarine bioresources. Organizations
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such as the World Ocean Council, an alliance on Corporate Ocean Responsibility and Ocean Recovery Alliance which is a
non-for profit organization in California, can play a role in raising awareness among the stakeholders on benefit sharing
mechanisms aswell as sustainable use of the resources. Various legal instruments envisage promoting access and benefiting
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sharingmechanism for indigenous communities as itwill bring recognition and incentive for community development.With
active participation of traditional knowledge rich countries in the Conference of Parties of CBD, appropriate mechanisms for
ensuring access and benefit sharing can be developed. As proposed by Micro B3 project for Europe, agreements in line with
the national laws shall be more effective. The marine bioprospecting contracts can be a significant tool for the development
of a successful access and benefit sharing mechanism that will safeguard the interests of the indigenous communities as
well as monitor the use of marine bioresources in an environment friendly and sustainable manner.
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